{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:22:00Z","timestamp":1789176120699,"version":"build-2803163510"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,6]]},"DOI":"10.7759\/cureus.66341","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T02:18:14Z","timestamp":1722997094000},"source":"Crossref","is-referenced-by-count":4,"title":["Optimizing Cardiovascular Health: A Comprehensive Review of Risk Assessment Strategies for Primary Prevention"],"prefix":"10.7759","author":[{"given":"Vineet","family":"Karwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Wanjari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushikesh H","family":"Dhondge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajvardhan","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjeet","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1288","article-title":"The heart of the world","volume":"19","author":"Di Cesare M","year":"2024","unstructured":"Di Cesare M, Perel P, Taylor S, et al.. The heart of the world. Glob Heart. 2024, 19:11. 10.5334\/gh.1288","journal-title":"Glob Heart"},{"key":"ref2","article-title":"Coronary Artery Disease Prevention","author":"Regmi M","year":"2024","unstructured":"Regmi M, Siccardi MA. Coronary Artery Disease Prevention. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref3","article-title":"Reducing the burden of cardiovascular disease: intervention approaches","author":"Institute of Medicine (US)","year":"2010","unstructured":"Institute of Medicine (US). Reducing the burden of cardiovascular disease: intervention approaches. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health. Fuster V, Kelly BB (ed): National Academies Press (US), Washington, DC; 2010."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12071140","article-title":"The need for individualized risk assessment in cardiovascular disease","volume":"12","author":"Lim HY","year":"2022","unstructured":"Lim HY, Burrell LM, Brook R, Nandurkar HH, Donnan G, Ho P. The need for individualized risk assessment in cardiovascular disease. J Pers Med. 2022, 12:1140. 10.3390\/jpm12071140","journal-title":"J Pers Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1177\/2048872619858285","article-title":"Risk prediction tools in cardiovascular disease prevention: a report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)","volume":"9","author":"Rossello X","year":"2020","unstructured":"Rossello X, Dorresteijn JA, Janssen A, et al.. Risk prediction tools in cardiovascular disease prevention: a report from the ESC Prevention of CVD Programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the Acute Cardiovascular Care Association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP). Eur Heart J Acute Cardiovasc Care. 2020, 9:522-32. 10.1177\/2048872619858285","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1639634","article-title":"The role of cardiovascular risk assessment in preventive medicine: a perspective from Portugal primary health-care cardiovascular risk assessment","volume":"2020","author":"Santos P","year":"2020","unstructured":"Santos P. The role of cardiovascular risk assessment in preventive medicine: a perspective from Portugal primary health-care cardiovascular risk assessment. J Environ Public Health. 2020, 2020:1639634. 10.1155\/2020\/1639634","journal-title":"J Environ Public Health"},{"key":"ref7","article-title":"Risk Factors for Coronary Artery Disease","author":"Brown JC","year":"2024","unstructured":"Brown JC, Gerhardt TE, Kwon E. Risk Factors for Coronary Artery Disease. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref8","article-title":"Hypertensive Heart Disease","author":"Tackling G","year":"2024","unstructured":"Tackling G, Borhade MB. Hypertensive Heart Disease. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref9","article-title":"Dyslipidemia","author":"Pappan N","year":"2024","unstructured":"Pappan N, Awosika AO, Rehman A. Dyslipidemia. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref10","article-title":"How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General","author":"Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US)","year":"2010","unstructured":"Centers for Disease Control and Prevention (US); National Center for Chronic Disease Prevention and Health Promotion (US); Office on Smoking and Health (US). How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Centers for Disease Control and Prevention (US), Atlanta, GA; 2010."},{"key":"ref11","article-title":"Relationships among major risk factors and the burden of cardiovascular diseases, diabetes, and chronic lung disease","author":"Ajay VS","year":"2017","unstructured":"Ajay VS, Watkins DA, Prabhakaran D. Relationships among major risk factors and the burden of cardiovascular diseases, diabetes, and chronic lung disease. Cardiovascular, Respiratory, and Related Disorders.  3rd Edition. Prabhakaran D, Anand S, Gaziano TA, et al. (ed): The International Bank for Reconstruction and Development\/The World Bank, Washington, DC; 2017."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000638","article-title":"Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American Heart Association and American College of Cardiology","volume":"139","author":"Lloyd-Jones DM","year":"2019","unstructured":"Lloyd-Jones DM, Braun LT, Ndumele CE, Smith SC Jr, Sperling LS, Virani SS, Blumenthal RS. Use of risk assessment tools to guide decision-making in the primary prevention of atherosclerotic cardiovascular disease: a special report from the American Heart Association and American College of Cardiology. Circulation. 2019, 139:e1162-77. 10.1161\/CIR.0000000000000638","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11092353","article-title":"Non-conventional risk factors: \"fact\" or \"fake\" in cardiovascular disease prevention?","volume":"11","author":"Cimmino G","year":"2023","unstructured":"Cimmino G, Natale F, Alfieri R, et al.. Non-conventional risk factors: \"fact\" or \"fake\" in cardiovascular disease prevention?. Biomedicines. 2023, 11:2353. 10.3390\/biomedicines11092353","journal-title":"Biomedicines"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1590\/0100-3984.2015.0235","article-title":"Coronary artery calcium score: current status","volume":"50","author":"Neves PO","year":"2017","unstructured":"Neves PO, Andrade J, Mon\u00e7\u00e3o H. Coronary artery calcium score: current status. Radiol Bras. 2017, 50:182-9. 10.1590\/0100-3984.2015.0235","journal-title":"Radiol Bras"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11100690","article-title":"Apolipoprotein B and cardiovascular disease: biomarker and potential therapeutic target","volume":"11","author":"Behbodikhah J","year":"2021","unstructured":"Behbodikhah J, Ahmed S, Elyasi A, Kasselman LJ, De Leon J, Glass AD, Reiss AB. Apolipoprotein B and cardiovascular disease: biomarker and potential therapeutic target. Metabolites. 2021, 11:690. 10.3390\/metabo11100690","journal-title":"Metabolites"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/0300-1652.170384","article-title":"Sonographic assessment of the carotid intima-media thickness on B-mode ultrasonography in a Nigerian population","volume":"56","author":"Ayoola OO","year":"2015","unstructured":"Ayoola OO, Onuwaje MA, Akintomide AO. Sonographic assessment of the carotid intima-media thickness on B-mode ultrasonography in a Nigerian population. Niger Med J. 2015, 56:357-61. 10.4103\/0300-1652.170384","journal-title":"Niger Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clp.2011.06.007","article-title":"The contribution of maternal stress to preterm birth: issues and considerations","volume":"38","author":"Wadhwa PD","year":"2011","unstructured":"Wadhwa PD, Entringer S, Buss C, Lu MC. The contribution of maternal stress to preterm birth: issues and considerations. Clin Perinatol. 2011, 38:351-84. 10.1016\/j.clp.2011.06.007","journal-title":"Clin Perinatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.306458","article-title":"Environmental determinants of cardiovascular disease","volume":"121","author":"Bhatnagar A","year":"2017","unstructured":"Bhatnagar A. Environmental determinants of cardiovascular disease. Circ Res. 2017, 121:162-80. 10.1161\/CIRCRESAHA.117.306458","journal-title":"Circ Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s41043-017-0114-0","article-title":"Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome","volume":"36","author":"Jahangiry L","year":"2017","unstructured":"Jahangiry L, Farhangi MA, Rezaei F. Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome. J Health Popul Nutr. 2017, 36:36. 10.1186\/s41043-017-0114-0","journal-title":"J Health Popul Nutr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-020-01246-2","article-title":"Performance of the Framingham coronary heart disease risk score for predicting 10-year cardiac risk in adult United Arab Emirates nationals without diabetes: a retrospective cohort study","volume":"21","author":"Al-Shamsi S","year":"2020","unstructured":"Al-Shamsi S. Performance of the Framingham coronary heart disease risk score for predicting 10-year cardiac risk in adult United Arab Emirates nationals without diabetes: a retrospective cohort study. BMC Fam Pract. 2020, 21:175. 10.1186\/s12875-020-01246-2","journal-title":"BMC Fam Pract"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-017-0225-1","article-title":"Cardiovascular risk assessment in patients with diabetes","volume":"9","author":"Bertoluci MC","year":"2017","unstructured":"Bertoluci MC, Rocha VZ. Cardiovascular risk assessment in patients with diabetes. Diabetol Metab Syndr. 2017, 9:25. 10.1186\/s13098-017-0225-1","journal-title":"Diabetol Metab Syndr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a3083","article-title":"Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study","volume":"338","author":"De Ruijter W","year":"2009","unstructured":"De Ruijter W, Westendorp RG, Assendelft WJ, den Elzen WP, de Craen AJ, le Cessie S, Gussekloo J. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2009, 338:a3083. 10.1136\/bmj.a3083","journal-title":"BMJ"},{"key":"ref23","article-title":"The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study","volume":"55","author":"Brindle PM","year":"2005","unstructured":"Brindle PM, McConnachie A, Upton MN, Hart CL, Smith GD, Watt GC. The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study. Br J Gen Pract. 2005, 55:838-45.","journal-title":"Br J Gen Pract"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/nursrep11020041","article-title":"Fall risk assessment scales: a systematic literature review","volume":"11","author":"Strini V","year":"2021","unstructured":"Strini V, Schiavolin R, Prendin A. Fall risk assessment scales: a systematic literature review. Nurs Rep. 2021, 11:430-43. 10.3390\/nursrep11020041","journal-title":"Nurs Rep"},{"key":"ref25","unstructured":"ASCVD (atherosclerotic cardiovascular disease) 2013 risk calculator from AHA\/ACC. (2013). Accessed. July 21, 2024: https:\/\/www.mdcalc.com\/calc\/3398\/ascvd-atherosclerotic-cardiovascular-disease-2013-risk-calculator-aha-acc."},{"key":"ref26","unstructured":"ASCVD risk estimator. (2024). Accessed. July 21, 2024: https:\/\/tools.acc.org\/ascvd-risk-estimator\/default.aspx."},{"key":"ref27","unstructured":"QRISK. a comprehensive guide to cardiovascular disease risk assessment with PocDoc. (2024). Accessed: July 21, 2024: https:\/\/pocdoc.co\/articles\/pocdoc-cardiovascular-disease-risk-using-qrisk."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39261.471806.55","article-title":"Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study","volume":"335","author":"Hippisley-Cox J","year":"2007","unstructured":"Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, May M, Brindle P. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ. 2007, 335:136. 10.1136\/bmj.39261.471806.55","journal-title":"BMJ"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.15281","article-title":"Multiple imputation: a flexible tool for handling missing data","volume":"314","author":"Li P","year":"2015","unstructured":"Li P, Stuart EA, Allison DB. Multiple imputation: a flexible tool for handling missing data. JAMA. 2015, 314:1966-7. 10.1001\/jama.2015.15281","journal-title":"JAMA"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c2442","article-title":"An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study","volume":"340","author":"Collins GS","year":"2010","unstructured":"Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ. 2010, 340:c2442. 10.1136\/bmj.c2442","journal-title":"BMJ"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.052430","article-title":"Quantifying and understanding the higher risk of atherosclerotic cardiovascular disease among South Asian individuals: results from the UK Biobank prospective cohort study","volume":"144","author":"Patel AP","year":"2021","unstructured":"Patel AP, Wang M, Kartoun U, Ng K, Khera AV. Quantifying and understanding the higher risk of atherosclerotic cardiovascular disease among South Asian individuals: results from the UK Biobank prospective cohort study. Circulation. 2021, 144:410-22. 10.1161\/CIRCULATIONAHA.120.052430","journal-title":"Circulation"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12071180","article-title":"Cardiovascular risk prediction models and scores in the era of personalized medicine","volume":"12","author":"Sofogianni A","year":"2022","unstructured":"Sofogianni A, Stalikas N, Antza C, Tziomalos K. Cardiovascular risk prediction models and scores in the era of personalized medicine. J Pers Med. 2022, 12:1180. 10.3390\/jpm12071180","journal-title":"J Pers Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.814251","article-title":"C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men","volume":"118","author":"Ridker PM","year":"2008","unstructured":"Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR. C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation. 2008, 118:2243-51, 4p following 2251. 10.1161\/CIRCULATIONAHA.108.814251","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio1322","article-title":"The use of high-sensitivity assays for C-reactive protein in clinical practice","volume":"5","author":"Musunuru K","year":"2008","unstructured":"Musunuru K, Kral BG, Blumenthal RS, et al.. The use of high-sensitivity assays for C-reactive protein in clinical practice. Nat Clin Pract Cardiovasc Med. 2008, 5:621-35. 10.1038\/ncpcardio1322","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2217\/whe.13.44","article-title":"Predictors of cardiovascular risk in women","volume":"9","author":"Sallam T","year":"2013","unstructured":"Sallam T, Watson KE. Predictors of cardiovascular risk in women. Womens Health (Lond). 2013, 9:491-8. 10.2217\/whe.13.44","journal-title":"Womens Health (Lond)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05640-y","article-title":"Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings","volume":"65","author":"Dziopa K","year":"2022","unstructured":"Dziopa K, Asselbergs FW, Gratton J, Chaturvedi N, Schmidt AF. Cardiovascular risk prediction in type 2 diabetes: a comparison of 22 risk scores in primary care settings. Diabetologia. 2022, 65:644-56. 10.1007\/s00125-021-05640-y","journal-title":"Diabetologia"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.11909\/j.issn.1671-5411.2017.02.008","article-title":"Novel biomarkers for cardiovascular risk prediction","volume":"14","author":"Wang J","year":"2017","unstructured":"Wang J, Tan GJ, Han LN, Bai YY, He M, Liu HB. Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol. 2017, 14:135-50. 10.11909\/j.issn.1671-5411.2017.02.008","journal-title":"J Geriatr Cardiol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001077","article-title":"Polygenic risk scores for cardiovascular disease: a scientific statement from the American Heart Association","volume":"146","author":"O'Sullivan JW","year":"2022","unstructured":"O'Sullivan JW, Raghavan S, Marquez-Luna C, et al.. Polygenic risk scores for cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2022, 146:e93-e118. 10.1161\/CIR.0000000000001077","journal-title":"Circulation"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12175563","article-title":"Role of cardiovascular imaging in risk assessment: recent advances, gaps in evidence, and future directions","volume":"12","author":"Perone F","year":"2023","unstructured":"Perone F, Bernardi M, Redheuil A, et al.. Role of cardiovascular imaging in risk assessment: recent advances, gaps in evidence, and future directions. J Clin Med. 2023, 12:5563. 10.3390\/jcm12175563","journal-title":"J Clin Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2022.100335","article-title":"Atherosclerotic cardiovascular disease risk assessment: an American Society for Preventive Cardiology clinical practice statement","volume":"10","author":"Wong ND","year":"2022","unstructured":"Wong ND, Budoff MJ, Ferdinand K, et al.. Atherosclerotic cardiovascular disease risk assessment: an American Society for Preventive Cardiology clinical practice statement. Am J Prev Cardiol. 2022, 10:100335. 10.1016\/j.ajpc.2022.100335","journal-title":"Am J Prev Cardiol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S379874","article-title":"A heart-healthy diet for cardiovascular disease prevention: where are we now?","volume":"19","author":"Diab A","year":"2023","unstructured":"Diab A, Dastmalchi LN, Gulati M, Michos ED. A heart-healthy diet for cardiovascular disease prevention: where are we now?. Vasc Health Risk Manag. 2023, 19:237-53. 10.2147\/VHRM.S379874","journal-title":"Vasc Health Risk Manag"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw319","article-title":"Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies","volume":"46","author":"Aune D","year":"2017","unstructured":"Aune D, Giovannucci E, Boffetta P, et al.. Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies. Int J Epidemiol. 2017, 46:1029-56. 10.1093\/ije\/dyw319","journal-title":"Int J Epidemiol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.10.014","article-title":"The Mediterranean diet, its components, and cardiovascular disease","volume":"128","author":"Widmer RJ","year":"2015","unstructured":"Widmer RJ, Flammer AJ, Lerman LO, Lerman A. The Mediterranean diet, its components, and cardiovascular disease. Am J Med. 2015, 128:229-38. 10.1016\/j.amjmed.2014.10.014","journal-title":"Am J Med"},{"key":"ref44","article-title":"DASH Diet to Stop Hypertension","author":"Challa HJ","year":"2024","unstructured":"Challa HJ, Ameer MA, Uppaluri KR. DASH Diet to Stop Hypertension. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref45","unstructured":"Physical activity and your heart - benefits | NHLBI, NIH. (2022). Accessed. July 21, 2024: https:\/\/www.nhlbi.nih.gov\/health\/heart\/physical-activity\/benefits."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.84.s1.03","article-title":"The essential role of exercise in the management of type 2 diabetes","volume":"84","author":"Kirwan JP","year":"2017","unstructured":"Kirwan JP, Sacks J, Nieuwoudt S. The essential role of exercise in the management of type 2 diabetes. Cleve Clin J Med. 2017, 84:S15-21. 10.3949\/ccjm.84.s1.03","journal-title":"Cleve Clin J Med"},{"key":"ref47","unstructured":"American Heart Association recommendations for physical activity in adults and kids. (2024). Accessed. July 21, 2024: https:\/\/www.heart.org\/en\/healthy-living\/fitness\/fitness-basics\/aha-recs-for-physical-activity-in-adults."},{"key":"ref48","unstructured":"Aerobic exercise examples. how to, benefits, and more. (2022). Accessed: July 21, 2024: https:\/\/www.healthline.com\/health\/fitness-exercise\/aerobic-exercise-examples."},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2018.00135","article-title":"Cardiovascular effects and benefits of exercise","volume":"5","author":"Nystoriak MA","year":"2018","unstructured":"Nystoriak MA, Bhatnagar A. Cardiovascular effects and benefits of exercise. Front Cardiovasc Med. 2018, 5:135. 10.3389\/fcvm.2018.00135","journal-title":"Front Cardiovasc Med"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207711","article-title":"Adipokines and inflammation: focus on cardiovascular diseases","volume":"21","author":"Feij\u00f3o-Band\u00edn S","year":"2020","unstructured":"Feij\u00f3o-Band\u00edn S, Arag\u00f3n-Herrera A, Mora\u00f1a-Fern\u00e1ndez S, et al.. Adipokines and inflammation: focus on cardiovascular diseases. Int J Mol Sci. 2020, 21:7711. 10.3390\/ijms21207711","journal-title":"Int J Mol Sci"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314982","article-title":"The role of adipokines in inflammatory mechanisms of obesity","volume":"23","author":"Kirichenko TV","year":"2022","unstructured":"Kirichenko TV, Markina YV, Bogatyreva AI, Tolstik TV, Varaeva YR, Starodubova AV. The role of adipokines in inflammatory mechanisms of obesity. Int J Mol Sci. 2022, 23:14982. 10.3390\/ijms232314982","journal-title":"Int J Mol Sci"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.768119","article-title":"Obesity and cardiovascular disease: the emerging role of inflammation","volume":"8","author":"Khafagy R","year":"2021","unstructured":"Khafagy R, Dash S. Obesity and cardiovascular disease: the emerging role of inflammation. Front Cardiovasc Med. 2021, 8:768119. 10.3389\/fcvm.2021.768119","journal-title":"Front Cardiovasc Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1037\/amp0000517","article-title":"Lifestyle modification approaches for the treatment of obesity in adults","volume":"75","author":"Wadden TA","year":"2020","unstructured":"Wadden TA, Tronieri JS, Butryn ML. Lifestyle modification approaches for the treatment of obesity in adults. Am Psychol. 2020, 75:235-51. 10.1037\/amp0000517","journal-title":"Am Psychol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42616","article-title":"Impact of lifestyle modifications on cardiovascular health: a narrative review","volume":"15","author":"Ghodeshwar GK","year":"2023","unstructured":"Ghodeshwar GK, Dube A, Khobragade D. Impact of lifestyle modifications on cardiovascular health: a narrative review. Cureus. 2023, 15:e42616. 10.7759\/cureus.42616","journal-title":"Cureus"},{"key":"ref55","article-title":"Pharmacologic Therapy for Obesity","author":"Rodrigues Silva Sombra L","year":"2024","unstructured":"Rodrigues Silva Sombra L, Anastasopoulou C. Pharmacologic Therapy for Obesity. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2017.08.012","article-title":"Maintenance of lost weight and long-term management of obesity","volume":"102","author":"Hall KD","year":"2018","unstructured":"Hall KD, Kahan S. Maintenance of lost weight and long-term management of obesity. Med Clin North Am. 2018, 102:183-97. 10.1016\/j.mcna.2017.08.012","journal-title":"Med Clin North Am"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2020.02.47","article-title":"Cardiovascular risk of smoking and benefits of smoking cessation","volume":"12","author":"Gallucci G","year":"2020","unstructured":"Gallucci G, Tartarone A, Lerose R, Lalinga AV, Capobianco AM. Cardiovascular risk of smoking and benefits of smoking cessation. J Thorac Dis. 2020, 12:3866-76. 10.21037\/jtd.2020.02.47","journal-title":"J Thorac Dis"},{"key":"ref58","unstructured":"Smoking and your heart - how smoking affects the heart and blood vessels | NHLBI, NIH. (2022). Accessed. July 21, 2024: https:\/\/www.nhlbi.nih.gov\/health\/heart\/smoking."},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.704106","article-title":"Smoking and the pathophysiology of peripheral artery disease","volume":"8","author":"Wang W","year":"2021","unstructured":"Wang W, Zhao T, Geng K, Yuan G, Chen Y, Xu Y. Smoking and the pathophysiology of peripheral artery disease. Front Cardiovasc Med. 2021, 8:704106. 10.3389\/fcvm.2021.704106","journal-title":"Front Cardiovasc Med"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.52102","article-title":"A review of smoking cessation interventions: efficacy, strategies for implementation, and future directions","volume":"16","author":"Onwuzo CN","year":"2024","unstructured":"Onwuzo CN, Olukorode J, Sange W, et al.. A review of smoking cessation interventions: efficacy, strategies for implementation, and future directions. Cureus. 2024, 16:e52102. 10.7759\/cureus.52102","journal-title":"Cureus"},{"key":"ref61","unstructured":"What are treatments for tobacco dependence? | National Institute on Drug Abuse (NIDA). (2023). Accessed. July 21, 2024: https:\/\/nida.nih.gov\/publications\/research-reports\/tobacco-nicotine-e-cigarettes\/what-are-treatments-tobacco-dependence."},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001007.pub3","article-title":"Group behaviour therapy programmes for smoking cessation","volume":"3","author":"Stead LF","year":"2017","unstructured":"Stead LF, Carroll AJ, Lancaster T. Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev. 2017, 3:CD001007. 10.1002\/14651858.CD001007.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref63","unstructured":"Quit smoking plan | tips to quit smoking | steps to quit. (2023). Accessed. July 21, 2024: https:\/\/www.cancer.org\/cancer\/risk-prevention\/tobacco\/guide-quitting-smoking\/deciding-to-quit-smoking-and-making-a-pl...."},{"key":"ref64","article-title":"HMG-CoA Reductase Inhibitors","author":"Bansal AB","year":"2024","unstructured":"Bansal AB, Cassagnol M. HMG-CoA Reductase Inhibitors. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-10-0110","article-title":"Pleiotropic effects of statins: basic research and clinical perspectives","volume":"74","author":"Zhou Q","year":"2010","unstructured":"Zhou Q, Liao JK. Pleiotropic effects of statins: basic research and clinical perspectives. Circ J. 2010, 74:818-26. 10.1253\/circj.cj-10-0110","journal-title":"Circ J"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.906479","article-title":"Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials","volume":"121","author":"Mora S","year":"2010","unstructured":"Mora S, Glynn RJ, Hsia J, MacFadyen JG, Genest J, Ridker PM. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation. 2010, 121:1069-77. 10.1161\/CIRCULATIONAHA.109.906479","journal-title":"Circulation"},{"key":"ref67","article-title":"Statin Medications","author":"Sizar O","year":"2024","unstructured":"Sizar O, Khare S, Patel P, Talati R. Statin Medications. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref68","article-title":"Antihypertensive Medications","author":"Khalil H","year":"2024","unstructured":"Khalil H, Zeltser R. Antihypertensive Medications. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref69","article-title":"ACE Inhibitors","author":"Goyal A","year":"2024","unstructured":"Goyal A, Cusick AS, Thielemier B. ACE Inhibitors. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.250","article-title":"Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis","volume":"305","author":"Thompson AM","year":"2011","unstructured":"Thompson AM, Hu T, Eshelbrenner CL, Reynolds K, He J, Bazzano LA. Antihypertensive treatment and secondary prevention of cardiovascular disease events among persons without hypertension: a meta-analysis. JAMA. 2011, 305:913-22. 10.1001\/jama.2011.250","journal-title":"JAMA"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.15420\/cfr.2020.19","article-title":"Cardiovascular outcomes in trials of new antidiabetic drug classes","volume":"7","author":"Lo CW","year":"2021","unstructured":"Lo CW, Fei Y, Cheung BM. Cardiovascular outcomes in trials of new antidiabetic drug classes. Card Fail Rev. 2021, 7:e04. 10.15420\/cfr.2020.19","journal-title":"Card Fail Rev"},{"key":"ref72","article-title":"Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors","author":"Padda IS","year":"2024","unstructured":"Padda IS, Mahtani AU, Parmar M. Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref73","article-title":"Glucagon-Like Peptide-1 Receptor Agonists","author":"Collins L","year":"2024","unstructured":"Collins L, Costello RA. Glucagon-Like Peptide-1 Receptor Agonists. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17519","article-title":"Protective effects of metformin in various cardiovascular diseases: clinical evidence and AMPK-dependent mechanisms","volume":"26","author":"Bu Y","year":"2022","unstructured":"Bu Y, Peng M, Tang X, Xu X, Wu Y, Chen AF, Yang X. Protective effects of metformin in various cardiovascular diseases: clinical evidence and AMPK-dependent mechanisms. J Cell Mol Med. 2022, 26:4886-903. 10.1111\/jcmm.17519","journal-title":"J Cell Mol Med"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-022-01740-2","article-title":"Aspirin for primary prevention of cardiovascular diseases: \"WALTZ\" with the evidence","volume":"24","author":"Dimitriadis K","year":"2022","unstructured":"Dimitriadis K, Lazarou E, Tsioufis P, Soulaidopoulos S, Tsioufis K. Aspirin for primary prevention of cardiovascular diseases: \"WALTZ\" with the evidence. Curr Cardiol Rep. 2022, 24:1139-47. 10.1007\/s11886-022-01740-2","journal-title":"Curr Cardiol Rep"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s11845-021-02649-5","article-title":"Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings","volume":"191","author":"Tan SY","year":"2022","unstructured":"Tan SY, Cronin H, Byrne S, O'Donovan A, Tuthill A. Appropriateness of aspirin prescribing for primary and secondary prevention of cardiovascular disease in type 2 diabetes in different care settings. Ir J Med Sci. 2022, 191:1185-91. 10.1007\/s11845-021-02649-5","journal-title":"Ir J Med Sci"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.4983","article-title":"Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement","volume":"327","author":"Davidson KW","year":"2022","unstructured":"Davidson KW, Barry MJ, Mangione CM, et al.. Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement. JAMA. 2022, 327:1577-84. 10.1001\/jama.2022.4983","journal-title":"JAMA"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22474-9","article-title":"Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease","volume":"12","author":"Haim-Pinhas H","year":"2022","unstructured":"Haim-Pinhas H, Yoskovitz G, Lishner M, et al.. Effect of aspirin on primary prevention of cardiovascular disease and mortality among patients with chronic kidney disease. Sci Rep. 2022, 12:17788. 10.1038\/s41598-022-22474-9","journal-title":"Sci Rep"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren FL","year":"2021","unstructured":"Visseren FL, Mach F, Smulders YM, et al.. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021, 42:3227-337. 10.1093\/eurheartj\/ehab484","journal-title":"Eur Heart J"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.52280","article-title":"2023 Australian guideline for assessing and managing cardiovascular disease risk","volume":"220","author":"Nelson MR","year":"2024","unstructured":"Nelson MR, Banks E, Brown A, et al.. 2023 Australian guideline for assessing and managing cardiovascular disease risk. Med J Aust. 2024, 220:482-90. 10.5694\/mja2.52280","journal-title":"Med J Aust"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000677","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"140","author":"Arnett DK","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, et al.. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation. 2019, 140:e563-95. 10.1161\/CIR.0000000000000677","journal-title":"Circulation"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001201","article-title":"Use of artificial intelligence in improving outcomes in heart disease: a scientific statement from the American Heart Association","volume":"149","author":"Armoundas AA","year":"2024","unstructured":"Armoundas AA, Narayan SM, Arnett DK, et al.. Use of artificial intelligence in improving outcomes in heart disease: a scientific statement from the American Heart Association. Circulation. 2024, 149:e1028-50. 10.1161\/CIR.0000000000001201","journal-title":"Circulation"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2020.07.027","article-title":"Barriers to implementing cardiovascular risk calculation in primary care: alignment with the consolidated framework for implementation research","volume":"60","author":"Tuzzio L","year":"2021","unstructured":"Tuzzio L, O'Meara ES, Holden E, Parchman ML, Ralston JD, Powell JA, Baldwin LM. Barriers to implementing cardiovascular risk calculation in primary care: alignment with the consolidated framework for implementation research. Am J Prev Med. 2021, 60:250-7. 10.1016\/j.amepre.2020.07.027","journal-title":"Am J Prev Med"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.15171\/ijhpm.2014.65","article-title":"Factors influencing healthcare service quality","volume":"3","author":"Mosadeghrad AM","year":"2014","unstructured":"Mosadeghrad AM. Factors influencing healthcare service quality. Int J Health Policy Manag. 2014, 3:77-89. 10.15171\/ijhpm.2014.65","journal-title":"Int J Health Policy Manag"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.11909\/j.issn.1671-5411.2021.06.004","article-title":"Cardiovascular risk and aging: the need for a more comprehensive understanding","volume":"18","author":"Trtica Majnari\u0107 L","year":"2021","unstructured":"Trtica Majnari\u0107 L, Bosni\u0107 Z, Kurevija T, Wittlinger T. Cardiovascular risk and aging: the need for a more comprehensive understanding. J Geriatr Cardiol. 2021, 18:462-78. 10.11909\/j.issn.1671-5411.2021.06.004","journal-title":"J Geriatr Cardiol"},{"key":"ref86","unstructured":"Case study. primary prevention of cardiovascular disease. (2024). Accessed: April 26, 2024: https:\/\/nursingcenter.com\/ncblog\/february-2020\/case-study-primary-prevention-of-cardiovascular-di."},{"key":"ref87","unstructured":"Cardiovascular disease case studies. (2024). Accessed. July 21, 2024: https:\/\/www.bhf.org.uk\/for-professionals\/healthcare-professionals\/data-and-statistics\/international-cardiovascular-di...."},{"key":"ref88","article-title":"Guidelines for the Management of High Blood Cholesterol","author":"Grundy SM","year":"2000","unstructured":"Grundy SM, Feingold KR. Guidelines for the Management of High Blood Cholesterol. Feingold KR, Anawalt B, Blackman MR, et al. (ed): Endotext, South Dartmouth, MA; 2000."},{"key":"ref89","article-title":"The primary use of artificial intelligence in cardiovascular diseases: what kind of potential role does artificial intelligence play in future medicine?","volume":"16","author":"Yan Y","year":"2019","unstructured":"Yan Y, Zhang JW, Zang GY, Pu J. The primary use of artificial intelligence in cardiovascular diseases: what kind of potential role does artificial intelligence play in future medicine?. J Geriatr Cardiol. 2019, 16:585-91.","journal-title":"J Geriatr Cardiol"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10020322","article-title":"mHealth apps for self-management of cardiovascular diseases: a scoping review","volume":"10","author":"Cruz-Ramos NA","year":"2022","unstructured":"Cruz-Ramos NA, Alor-Hern\u00e1ndez G, Colombo-Mendoza LO, S\u00e1nchez-Cervantes JL, Rodr\u00edguez-Mazahua L, Guarneros-Nolasco LR. mHealth apps for self-management of cardiovascular diseases: a scoping review. Healthcare (Basel). 2022, 10:322. 10.3390\/healthcare10020322","journal-title":"Healthcare (Basel)"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2023.38.e395","article-title":"Polygenic risk score for cardiovascular diseases in artificial intelligence paradigm: a review","volume":"38","author":"Khanna NN","year":"2023","unstructured":"Khanna NN, Singh M, Maindarkar M, et al.. Polygenic risk score for cardiovascular diseases in artificial intelligence paradigm: a review. J Korean Med Sci. 2023, 38:e395. 10.3346\/jkms.2023.38.e395","journal-title":"J Korean Med Sci"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20140594","article-title":"Use of cardiac CT and calcium scoring for detecting coronary plaque: implications on prognosis and patient management","volume":"88","author":"Divakaran S","year":"2015","unstructured":"Divakaran S, Cheezum MK, Hulten EA, Bittencourt MS, Silverman MG, Nasir K, Blankstein R. Use of cardiac CT and calcium scoring for detecting coronary plaque: implications on prognosis and patient management. Br J Radiol. 2015, 88:20140594. 10.1259\/bjr.20140594","journal-title":"Br J Radiol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele CE","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, et al.. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation. 2023, 148:1606-35. 10.1161\/CIR.0000000000001184","journal-title":"Circulation"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-023-02350-w","article-title":"Smartwatches in healthcare medicine: assistance and monitoring; a scoping review","volume":"23","author":"Masoumian Hosseini M","year":"2023","unstructured":"Masoumian Hosseini M, Masoumian Hosseini ST, Qayumi K, Hosseinzadeh S, Sajadi Tabar SS. Smartwatches in healthcare medicine: assistance and monitoring; a scoping review. BMC Med Inform Decis Mak. 2023, 23:248. 10.1186\/s12911-023-02350-w","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.3892\/br.2017.922","article-title":"Personalized medicine could transform healthcare","volume":"7","author":"Mathur S","year":"2017","unstructured":"Mathur S, Sutton J. Personalized medicine could transform healthcare. Biomed Rep. 2017, 7:3-5. 10.3892\/br.2017.922","journal-title":"Biomed Rep"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.05.006","article-title":"Personalized medicine: motivation, challenges, and progress","volume":"109","author":"Goetz LH","year":"2018","unstructured":"Goetz LH, Schork NJ. Personalized medicine: motivation, challenges, and progress. Fertil Steril. 2018, 109:952-63. 10.1016\/j.fertnstert.2018.05.006","journal-title":"Fertil Steril"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1200\/PO.20.00513","article-title":"Integrating somatic and germline next-generation sequencing into routine clinical oncology practice","volume":"5","author":"Hicks JK","year":"2021","unstructured":"Hicks JK, Howard R, Reisman P, et al.. Integrating somatic and germline next-generation sequencing into routine clinical oncology practice. JCO Precis Oncol. 2021, 5:PO.20.00513. 10.1200\/PO.20.00513","journal-title":"JCO Precis Oncol"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2023.100561","article-title":"Multi-omics profiling for health","volume":"22","author":"Babu M","year":"2023","unstructured":"Babu M, Snyder M. Multi-omics profiling for health. Mol Cell Proteomics. 2023, 22:100561. 10.1016\/j.mcpro.2023.100561","journal-title":"Mol Cell Proteomics"},{"key":"ref99","unstructured":"Emerging techniques for cardiovascular risk assessment and prevention. (2024). Accessed. July 21, 2024: https:\/\/www.acc.org\/Latest-in-Cardiology\/Articles\/2022\/09\/12\/11\/09\/Emerging-Techniques-For-Cardiovascular-Risk-Assess...."},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-020-00889-x","article-title":"Digital health innovations to improve cardiovascular disease care","volume":"22","author":"Santo K","year":"2020","unstructured":"Santo K, Redfern J. Digital health innovations to improve cardiovascular disease care. Curr Atheroscler Rep. 2020, 22:71. 10.1007\/s11883-020-00889-x","journal-title":"Curr Atheroscler Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/280552-optimizing-cardiovascular-health-a-comprehensive-review-of-risk-assessment-strategies-for-primary-prevention","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T02:18:34Z","timestamp":1722997114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/280552-optimizing-cardiovascular-health-a-comprehensive-review-of-risk-assessment-strategies-for-primary-prevention"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":100,"URL":"https:\/\/doi.org\/10.7759\/cureus.66341","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,6]]}}}